Table 3 Differential analysis of inflammatory markers significantly correlated with 180-day mortality.
From: Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
Cell marker (NPX) | Deceased within 180 days, (n = 28) | Survived past 180 days, (n = 121) | Ancova | q-value |
|---|---|---|---|---|
Mean (SD) | Mean (SD) | Unadjusted p-value | ||
LIF | 1.96 (1.27) | 1.25 (0.49) | 0 | 0 |
uPA | 11.55 (0.55) | 11.20 (0.52) | 0 | 0.0009 |
IL-8 | 9.44 (1.53) | 8.52 (1.39) | 0.0001 | 0.0016 |
ENRAGE | 4.46 (1.69) | 3.33 (0.89) | 0.0001 | 0.0018 |
TGFa | 4.29 (0.72) | 3.87 (0.49) | 0.0001 | 0.0024 |
IL15-RA | 3.01 (0.78) | 2.61 (0.42) | 0.0003 | 0.0049 |
IL12-B | 6.29 (1.28) | 6.95 (1.06) | 0.0008 | 0.0103 |
MCP1 | 12.55 (0.68) | 12.18 (0.56) | 0.001 | 0.0114 |
CXCL6 | 10.36 (0.95) | 9.90 (0.87) | 0.0014 | 0.0136 |
HGF | 11.21 (1.04) | 10.72 (0.84) | 0.0015 | 0.0136 |
CASP8 | 4.06 (0.47) | 3.77 (0.51) | 0.0016 | 0.0137 |
CX3CL1 | 6.10 (0.56) | 5.76 (0.57) | 0.0018 | 0.0139 |
IL10-RB | 7.29 (0.27) | 7.09 (0.31) | 0.002 | 0.0144 |
CCL23 | 10.84 (0.66) | 10.36 (0.61) | 0.0025 | 0.0166 |
FGF19 | 10.20 (1.52) | 9.42 (1.33) | 0.0037 | 0.0226 |
IL-6 | 5.71 (1.41) | 4.91 (1.19) | 0.004 | 0.0232 |
TNFSF14 | 5.85 (0.84) | 5.46 (0.79) | 0.0046 | 0.024 |
ARTN | 2.48 (0.89) | 2.09 (0.59) | 0.0047 | 0.024 |
MCP3 | 2.96 (0.90) | 2.46 (0.64) | 0.0064 | 0.031 |
CCL20 | 11.46 (1.61) | 10.85 (1.33) | 0.0096 | 0.044 |
